PNOC037: A Phase 2 De-escalation Study of Dabrafenib and Trametinib for Patients with BRAF V600 Mutant Low-Grade Gliomas
Clinical Trial Grant
Awarded By
The Regents of the University of California
Start Date
December 10, 2025
End Date
August 31, 2028
Awarded By
The Regents of the University of California
Start Date
December 10, 2025
End Date
August 31, 2028